July 24, 2026
A Delaware bankruptcy judge has signed off on a deal resolving a $28.3 million claim by the buyer of defunct drug developer Akorn's assets, allowing an $18.5 million claim in the Chapter 7 case.
August 23, 2024
Defunct drug manufacturer Akorn has told Delaware's bankruptcy court it reached an agreement resolving a roughly $28 million dispute regarding its prepetition sale of pharmaceuticals to distributor Cardinal Health, which promised to pay nearly $7 million to the debtor's Chapter 7 estate.
February 24, 2023
Remnants of recently bankrupt specialty pharmaceutical venture Akorn Pharmaceuticals and two affiliates have crossed over from Chapter 11 to Chapter 7 liquidation in Delaware, with a worker complaint in tow alleging violations of federal plant closing and layoff regulations.